By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Anacor Pharmaceuticals, Inc. 

1060 East Meadow Circle

Palo Alto  California  94303  U.S.A.
Phone: 650-739-0700 Fax: 650-739-0139



Company News
Anacor (ANAC) To Present At The 2015 Wedbush PacGrow Healthcare Conference 8/10/2015 9:54:06 AM
Anacor (ANAC) Reports Second Quarter 2015 Financial Results 8/7/2015 7:56:00 AM
Anacor (ANAC)To Report Second Quarter 2015 Financial Results On August 6, 2015 7/24/2015 10:52:34 AM
Anacor (ANAC) To Host Conference Call Tomorrow, July 13, 2015 At 7:30 A.M. ET To Discuss Top-Line Results From Crisaborole Phase III Pivotal Studies In Patients With Mild-To-Moderate Atopic Dermatitis 7/13/2015 10:34:08 AM
Anacor (ANAC) Announces Positive Top-Line Results From Two Phase III Pivotal Studies Of Crisaborole Topical Ointment, 2% In Patients With Mild-To-Moderate Atopic Dermatitis 7/13/2015 6:21:32 AM
Anacor (ANAC) Hits Home Run with Crisaborole Phase III Trials, Predicts $1 Billion Potential Sales 7/13/2015 6:15:01 AM
Anacor Pharmaceuticals, Inc. (ANAC) Announces Amendment To KERYDIN Commercialization Agreement 6/29/2015 10:38:35 AM
Anacor Pharmaceuticals, Inc. (ANAC) Names Graeme Bell As New Executive Vice President And Chief Financial Officer 6/1/2015 1:47:40 PM
Anacor Pharmaceuticals, Inc. (ANAC) To Present At Upcoming Investor Conferences 5/28/2015 10:41:39 AM
Anacor Pharmaceuticals, Inc. (ANAC) Reports First Quarter 2015 Financial Results 5/7/2015 12:33:18 PM